Chronic Myeloid Leukemia BCR ABL

Practo

Tests

Gurgaon

Gurgaon Sector 28

Chronic Myeloid Leukemia BCR ABL

Showing labs for home sample tests

Book lab tests at home

  • Compare prices
  • • On-time home sample pick up
  • • On-time e-reports
PRACTO INTEGRATED LAB
Free home sample pick up
On time E-reports
NABL and CAP
438 tests booked
Free home sample pickup Next slot wednesday at 1:30 AM
Total: ₹4000
Book home sample
NABL and CAP
5 tests booked
Home sample pickup Next slot wednesday at 2:00 AM
Total: ₹5400
Book home sample
16 tests booked
Free home sample pickup Next slot wednesday at 3:00 AM
Total: ₹4600
Book home sample
Other labs
STATUS
You have no active orders!
mini-tick
Personalised health checkup
Get master health check-ups at home.
Starting at just ₹ 999 Book Now
Home Sample pickup

Test Information

Fusion of BCR/ABL1 is observed in all patients with chronic myeloid leukemia (CML), in approximately 25% of adult patients with precursor B-cell acute lymphoblastic leukemia (B-ALL) and in 1% of patients with pediatric B-ALL. The chromosome mechanism resulting in BCR/ABL1 fusion is a t(9;22)(q34;q11.2) in approximately 85%, a complex 9;22 translocation with 1 or more additional chromosomes in approximately 15% and a chromosomally "cryptic" or insertional translocation in fewer than 1% of patients. Conventional cytogenetic studies are still the gold standard for identification of the t(9;22) and to monitor the effectiveness of treatment in post-therapy bone marrow specimens. FISH testing for BCR/ABL1 fusion or RT-PCR testing for p190 or p210 fusion forms are the recommended tests for evaluation of minimal residual disease following the disappearance of the t(9;22) in a post-treatment chromosome analysis. BCR/ABL1/ASS can be performed on bone marrow or peripheral blood and can be used to establish the percentage of neoplastic interphase nuclei for patients with CML at diagnosis and at all times during treatment, even in cytogenetic remission. BCR/ABL1/ASS can detect all known forms of the Ph chromosome, all atypical patterns associated with t(9;22)(q34q11.2) and can detect low levels of residual disease. We recommend BCR/ABL1/ASS at diagnosis subsequently to monitor the response to therapy.

Also known as: Chronic Myeloid Leukemia BCR ABL FISH Blood, CML BCR ABL.

Have More Questions?

  • Why is this test required?
  • What are the test preparations?
  • What is the general cost of this test?
Know more